Suzhou Highfine Biotech Co., Ltd.

XSEC:301393 Stock Report

Market Cap: CN¥4.9b

Suzhou Highfine Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 301393?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,395,0144.11%
Private Companies7,290,0006.81%
General Public32,698,53830.6%
Individual Insiders62,588,30058.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 69.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
47.9%
Yong Zhu
51,192,000CN¥2.3b0%no data
4.89%
Xu Jie
5,234,000CN¥238.4m0.96%no data
4.54%
Ningbo Haoxin Enterprise Management Partnership Enterprise (Limited Partnership)
4,860,000CN¥221.3m0%no data
2.27%
Suzhou Haoqin Venture Capital Partnership Enterprise (Limited Partnership)
2,430,000CN¥110.7m0%no data
2.03%
Shengjun Dong
2,174,000CN¥99.0m11.8%no data
1.86%
Minjie Lv
1,994,300CN¥90.8m2.59%no data
1.86%
Xuegen Lu
1,994,000CN¥90.8m2.57%no data
1.16%
China Merchants Fund Management Company Ltd.
1,237,276CN¥56.3m0%0.03%
0.97%
Golden Trust SinoPac Fund Management Co., Ltd.
1,035,498CN¥47.2m0%0.41%
0.77%
Huatai-PineBridge Fund Management Co., Ltd.
822,332CN¥37.4m0%0.01%
0.41%
Galaxy Asset Management Co. Ltd.
437,642CN¥19.9m0%0.06%
0.33%
China International Capital Corporation Hong Kong Asset Management Limited
353,592CN¥16.1m0%0.08%
0.22%
National Council for Social Security Fund
239,155CN¥10.9m0%no data
0.029%
E Fund Management Co., Ltd.
30,640CN¥1.4m0%no data
0.026%
Fullgoal Fund Management Co. Ltd.
28,101CN¥1.3m0%no data
0.024%
China Southern Asset Management Co., Ltd.
26,021CN¥1.2m0%no data
0.019%
Zhong Ou Fund Management Co., Ltd
19,986CN¥910.0k0%no data
0.017%
Baijia Fund Management Co., Ltd.
17,700CN¥806.2k0%1.1%
0.015%
Harvest Fund Management Co. Ltd.
15,582CN¥709.8k0%no data
0.013%
Penghua Fund Management Co., Ltd.
14,032CN¥639.1k0%no data
0.013%
Yinhua Fund Management Co., Ltd.
13,400CN¥610.4k0%no data
0.011%
Tibet Eastmoney Fund Management Co.,Ltd.
12,100CN¥551.0k0%0.01%
0.01%
Manulife Asset Management
10,734CN¥488.6k0%no data
0.0088%
China Universal Asset Management Company Ltd.
9,361CN¥426.3k0%no data
0.0076%
Focusbridge Investments Limited
8,164CN¥371.7k0%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Suzhou Highfine Biotech Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Song YangTianfeng Securities Brokerage Co., Ltd